Correlation Between Cumberland Pharmaceuticals and Albemarle

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cumberland Pharmaceuticals and Albemarle at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cumberland Pharmaceuticals and Albemarle into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cumberland Pharmaceuticals and Albemarle, you can compare the effects of market volatilities on Cumberland Pharmaceuticals and Albemarle and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cumberland Pharmaceuticals with a short position of Albemarle. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cumberland Pharmaceuticals and Albemarle.

Diversification Opportunities for Cumberland Pharmaceuticals and Albemarle

-0.69
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Cumberland and Albemarle is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Cumberland Pharmaceuticals and Albemarle in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Albemarle and Cumberland Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cumberland Pharmaceuticals are associated (or correlated) with Albemarle. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Albemarle has no effect on the direction of Cumberland Pharmaceuticals i.e., Cumberland Pharmaceuticals and Albemarle go up and down completely randomly.

Pair Corralation between Cumberland Pharmaceuticals and Albemarle

Given the investment horizon of 90 days Cumberland Pharmaceuticals is expected to under-perform the Albemarle. In addition to that, Cumberland Pharmaceuticals is 1.16 times more volatile than Albemarle. It trades about -0.08 of its total potential returns per unit of risk. Albemarle is currently generating about 0.01 per unit of volatility. If you would invest  5,023  in Albemarle on August 28, 2024 and sell it today you would lose (58.00) from holding Albemarle or give up 1.15% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy88.94%
ValuesDaily Returns

Cumberland Pharmaceuticals  vs.  Albemarle

 Performance 
       Timeline  
Cumberland Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cumberland Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Albemarle 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Albemarle are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady fundamental drivers, Albemarle sustained solid returns over the last few months and may actually be approaching a breakup point.

Cumberland Pharmaceuticals and Albemarle Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cumberland Pharmaceuticals and Albemarle

The main advantage of trading using opposite Cumberland Pharmaceuticals and Albemarle positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cumberland Pharmaceuticals position performs unexpectedly, Albemarle can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Albemarle will offset losses from the drop in Albemarle's long position.
The idea behind Cumberland Pharmaceuticals and Albemarle pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities